Xiaoping Wu

861 total citations
23 papers, 319 citations indexed

About

Xiaoping Wu is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoping Wu has authored 23 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoping Wu's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (4 papers) and Liver Disease and Transplantation (4 papers). Xiaoping Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (4 papers) and Liver Disease and Transplantation (4 papers). Xiaoping Wu collaborates with scholars based in China, Hong Kong and Czechia. Xiaoping Wu's co-authors include Jingjing Li, Ruby L.C. Hoo, Li Zhao, Yi Zhang, Jing Yao, Qinglong Guo, Na Lu, Qidong You, Yue Zhao and Cunchuan Wang and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaoping Wu

18 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Wu China 10 97 77 59 49 45 23 319
Haixia Hu China 11 114 1.2× 36 0.5× 11 0.2× 44 0.9× 17 0.4× 22 301
Antonietta Fabbrocini Italy 9 123 1.3× 38 0.5× 38 0.6× 44 0.9× 29 0.6× 13 370
Zhijian Yu China 11 96 1.0× 67 0.9× 65 1.1× 55 1.1× 44 1.0× 23 306
Marwa A. Abdel-Dayem Egypt 10 141 1.5× 45 0.6× 28 0.5× 31 0.6× 44 1.0× 15 368
Xiaoxun Zhang China 11 132 1.4× 82 1.1× 49 0.8× 19 0.4× 37 0.8× 21 298
Shilei Wen China 11 221 2.3× 94 1.2× 78 1.3× 21 0.4× 62 1.4× 26 427
Jinghui Zheng China 9 230 2.4× 34 0.4× 20 0.3× 95 1.9× 32 0.7× 39 449
Wen Feng China 12 90 0.9× 26 0.3× 55 0.9× 74 1.5× 78 1.7× 31 316

Countries citing papers authored by Xiaoping Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wu more than expected).

Fields of papers citing papers by Xiaoping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wu. The network helps show where Xiaoping Wu may publish in the future.

Co-authorship network of co-authors of Xiaoping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Wu. A scholar is included among the top collaborators of Xiaoping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Wu. Xiaoping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Leung, Carmen Oi Ning, Martina Mang Leng Lei, Shakeel Ahmad Khan, et al.. (2025). Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver–induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activation. Journal of Clinical Investigation. 135(24).
3.
Ou, Weihua, et al.. (2025). MHS-VIT: Mamba hybrid self-attention vision transformers for traffic image detection. PLoS ONE. 20(6). e0325962–e0325962.
4.
5.
Li, Jingjing, Renkai Li, Xiaoping Wu, et al.. (2021). Amauroderma rugosum Protects PC12 Cells against 6‐OHDA‐Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects. Oxidative Medicine and Cellular Longevity. 2021(1). 6683270–6683270. 14 indexed citations
6.
Wu, Xiaoping, Lingling Shu, Zixuan Zhang, et al.. (2021). Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. Advanced Science. 8(11). e2003721–e2003721. 77 indexed citations
7.
Wu, Xiaoping, Ying Xiong, Fei Liu, et al.. (2020). HMGB1 Inhibits HNF1A to Modulate Liver Fibrogenesis via p65/miR-146b Signaling. DNA and Cell Biology. 39(9). 1711–1722. 13 indexed citations
8.
Chen, Yanbing, Ying Zhu, Juhua Xiao, et al.. (2019). SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3. Experimental Cell Research. 382(2). 111466–111466. 32 indexed citations
9.
Escalon, Joanna G., Xiaoping Wu, Lindsay Lief, et al.. (2017). Rare case of pulmonary involvement in an adult with Kawasaki disease. Clinical Imaging. 47. 1–3. 1 indexed citations
10.
Xiong, Ying, et al.. (2017). Role of growth factor receptor-bound 2 in CCl4-induced hepatic fibrosis. Biomedicine & Pharmacotherapy. 92. 942–951. 14 indexed citations
11.
Wu, Xiaoping, Robert J. Kaner, & Fernando J. Martínez. (2017). Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?. 3(2). 1 indexed citations
12.
Li, Xing, et al.. (2015). Experimental research of Fuaile medical adhesive for portal vein embolization in white rabbit models. Oncology Letters. 9(6). 2609–2616. 2 indexed citations
13.
14.
Zhang, Qian, Mengmeng Shang, Qufei Ling, Xiaoping Wu, & Chunyu Liu. (2014). Hepatoprotective effects of loach (Misgurnus anguillicaudatus) lyophilized powder on dimethylnitrosamine-induced liver fibrosis in rats. Archives of Pharmacal Research. 44(8). 1–12. 14 indexed citations
15.
Zhao, Yue, Jing Yao, Xiaoping Wu, et al.. (2014). Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL‐6/STAT3 signaling pathway. Molecular Carcinogenesis. 54(S1). E81–93. 65 indexed citations
16.
Wu, Xiaoping, et al.. (2012). The effect of core stability training on the motor function of patients with hemiplegia after stroke. Zhonghua wuli yixue zazhi. 34(5). 353–356. 1 indexed citations
17.
18.
Deng, Min, Minghui Li, Feng Liu, et al.. (2010). [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].. PubMed. 24(1). 21–3. 1 indexed citations
19.
Lin, Yun, Xiaoping Wu, Yi Shen, et al.. (2008). A novel antibody AA98 V(H)/L directed against CD146 efficiently inhibits angiogenesis.. PubMed. 27(6B). 4219–24. 13 indexed citations
20.
Yang, Hua, Jian Liu, Yimin Chen, et al.. (2002). [Value of three-dimensional digital subtraction angiography in diagnosis and planning endovascular treatment of cerebrovascular diseases].. PubMed. 82(10). 661–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haixia Hu Breakdown of academic impact, for papers by Antonietta Fabbrocini Breakdown of academic impact, for papers by Zhijian Yu Breakdown of academic impact, for papers by Marwa A. Abdel-Dayem Breakdown of academic impact, for papers by Xiaoxun Zhang Breakdown of academic impact, for papers by Shilei Wen Breakdown of academic impact, for papers by Jinghui Zheng Breakdown of academic impact, for papers by Wen Feng
Rankless by CCL
2026